Viatris (VTRS) Asset Utilization Ratio (2020 - 2026)
Viatris' (VTRS) quarterly Asset Utilization Ratio came in at 0.39 in Q1 2026, up 10.35% year-on-year from 0.36 in Q1 2025, and up 3.28% quarter-over-quarter from 0.38 in Q4 2025.
Viatris (VTRS) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Viatris' Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.39 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 10.35% year-over-year to 0.39 in Q1 2026; TTM through Mar 2026 was 0.39, a 10.35% increase from a year earlier, with the FY2025 full-year figure at 0.36, up 10.3% from the prior year.
- Asset Utilization Ratio rose to 0.39 in Q1 2026 per VTRS's latest filing, from 0.38 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.39 in Q1 2026 and bottomed at 0.32 in Q3 2023.
- The 5-year median for Asset Utilization Ratio is 0.33 (2022), against an average of 0.34.
- Across the five-year window, Asset Utilization Ratio soared 145.0% in 2022 and dropped 5.3% in 2023, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.33 in 2022, then fell by 3.21% to 0.32 in 2023, then increased by 6.72% to 0.34 in 2024, then advanced by 12.03% to 0.38 in 2025, then rose by 3.28% to 0.39 in 2026.
- Per Business Quant, the three latest VTRS Asset Utilization Ratio figures stand at 0.39 (Q1 2026), 0.38 (Q4 2025), and 0.37 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.33 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.32 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.22 |